Alimera Sciences Inc (ALIM) has gained 6.40% in a Week, Should You Sell?

Alimera Sciences Inc (ALIM) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. ALIM received an overall rating of 55, which means that it scores higher than 55 percent of all stocks. Alimera Sciences Inc also achieved a score of 87 in the Drug Manufacturers - Specialty & Generic industry, putting it above 87 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 139 out of the 148 industries.

ALIM has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on ALIM!

See Full ALIM Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 55 means the stock is more attractive than 55 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Alimera Sciences Inc Stock Today?

Alimera Sciences Inc (ALIM) stock has risen 7.6% while the S&P 500 is down -0.64% as of 12:44 PM on Thursday, Jun 9. ALIM is up $0.46 from the previous closing price of $6.02 on volume of 9,859 shares. Over the past year the S&P 500 has fallen -3.08% while ALIM is down -37.27%. ALIM lost -$1.02 per share the over the last 12 months. Click Here to get the full Stock Report for Alimera Sciences Inc stock.